Form 4: SI-BONE CFO Anshul Maheshwari Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Anshul Maheshwari, CFO of SI-BONE, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On July 2, 2024, Anshul Maheshwari, the Chief Financial Officer of SI-BONE, Inc., sold 1,556 shares of common stock at a weighted average price of $12.8973 and 1,753 shares of common stock at a weighted average price of $12.9067.
- The sales were executed in multiple trades within price ranges of $12.77 to $13.00 and $12.725 to $12.98, respectively.
- These transactions were conducted to cover tax withholding obligations associated with the vesting of restricted stock units and do not represent discretionary trades.
- Following the reported transactions, Maheshwari beneficially owns 201,180 shares of SI-BONE, Inc., including 138,180 shares issuable upon settlement of restricted stock units.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document simply reports stock sales for tax purposes, which is a common practice. It doesn't necessarily indicate a positive or negative outlook for the company.
Positives
- The sale was to cover tax obligations, indicating the vesting of restricted stock units, which can be seen as a form of compensation and alignment with company performance.
Future Outlook
There is no future outlook provided in this document.
Industry Context
This is a routine Form 4 filing, common for corporate insiders who trade company stock. It provides transparency into the transactions of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The transactions are typical for executives receiving stock-based compensation and managing their tax obligations.
- Similar filings are routinely made by executives at comparable companies like Globus Medical or NuVasive.
Key Dates
| Date | Description |
|---|---|
| April 19, 2021 | Date of Power of Attorney execution. |
| July 2, 2024 | Date of stock sale transactions. |
| July 5, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.